173
Views
3
CrossRef citations to date
0
Altmetric
Short Report

New magnetic resonance imaging sequences for fibrosis assessment in Crohn’s disease: a pilot study

, , , ORCID Icon, &
Pages 1450-1453 | Received 17 Mar 2022, Accepted 21 Jun 2022, Published online: 29 Sep 2022

References

  • Bettenworth D, Bokemeyer A, Baker M, Stenosis Therapy and Anti-Fibrotic Research (STAR) Consortium., et al. Assessment of Crohn’s disease-associated small bowel strictures and fibrosis on cross-sectional imaging: a systematic review. Gut. 2019;68(6):1115–1126.
  • Allocca M, Fiorino G, Bonifacio C, et al. Noninvasive multimodal methods to differentiate inflamed vs fibrotic strictures in patients with Crohn’s disease. Clin Gastroenterol Hepatol. 2019;17(12):2397–2415.
  • Allocca M, Danese S, Laurent V, et al. Use of cross-sectional imaging for tight monitoring of inflammatory bowel diseases. Clin Gastroenterol Hepatol. 2020;18(6):1309–1323.e4.
  • Mainenti PP, Castiglione F, Rispo A, et al. MR-enterography in Crohn’s disease: what MRE mural parameters are associated to one-year therapeutic management outcome? BJR. 2021;94(1118):20200844.
  • Castiglione F, Mainenti P, Testa A, et al. Cross-sectional evaluation of transmural healing in patients with Crohn’s disease on maintenance treatment with anti-TNF alpha agents. Dig Liver Dis. 2017;49(5):484–489.
  • Rispo A, Imperatore N, Testa A, et al. Bowel damage in Crohn’s Disease: direct comparison of ultrasonography-based and magnetic resonance-based Lemann index. Inflamm Bowel Dis. 2017;23(1):143–151.
  • Pouillon L, Laurent V, Pouillon M, et al. Diffusion-weighted MRI in inflammatory bowel disease. Lancet Gastroenterol Hepatol. 2018;3(6):3:433–443.
  • Alyami AS, Williams HG, Argyriou K, et al. Test-retest assessment of non-contrast MRI sequences to characterise and quantify the small bowel wall in healthy participants. MAGMA. 2021;34(6):791–804.
  • Heye T, Yang SR, Bock M, et al. MR relaxometry of the liver: significant elevation of T1 relaxation time in patients with liver cirrhosis. Eur Radiol. 2012;22(6):1224–1232.
  • Horsthuis K, Nederveen AJ, de Feiter MW, et al. Mapping of T1-values and gadolinium-concentrations in MRI as indicator of disease activity in luminal Crohn’s disease: a feasibility study. J Magn Reson Imaging. 2009;29(2):488–493.
  • Zhang MC, Li XH, Huang SY, et al. IVIM with fractional perfusion as a novel biomarker for detecting and grading intestinal fibrosis in Crohn’s disease. Eur Radiol. 2019;29(6):3069–3078.
  • Benchoufi M, Matzner-Lober E, Molinari N, et al. Interobserver agreement issues in radiology. Diagn Interv Imaging. 2020;101(10):639–641.
  • Avila F, Caron B, Hossu G, et al. Magnetic resonance elastography for assessing fibrosis in patients with Crohn’s disease: a pilot study. Dig Dis Sci. 2021. DOI:10.1007/s10620-021-07311-9
  • Djelouah M, Marical V, Kanagaratnam L, et al. Diagnosis of postoperative recurrence of Crohn disease with MR-enterography: value of diffusion-weighted imaging. Diagn Interv Imaging. 2021;102(12):743–751.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.